Top Healthcare stocks:
Healthcare shares were generally flat in pre-market trade on
In healthcare stocks news, biopharmaceutical company Cardiome
Pharma (CRME, COM.TO) said it has signed an agreement with
Austria-based AOP Orphan Pharmaceuticals to commercialize AGGRASTAT
in selected European markets.
AOP Orphan has agreed to specific annual commercial goals for
Financial details of the agreement were not disclosed.
CRME was steady before opening bell in the U.S. on Tuesday. It
closed at $7.74 Monday.
And, Stemline Therapeutics (
) said that a pre-clinical study at the Dana-Farber Cancer
Institute in Boston showed that its SL-401 significantly decreased
the viability of malignant cells by targeting neighboring
plasmacytoid dendritic cells in the tumor microenvironment of the
Also, Bioline RX (
) reported a smaller Q1 loss than the year before amid lower
research and development expenses.
The developer of therapeutics said its Q1 net loss narrowed to
7.4 million shekel ($2.1 million) or 0.03 shekel per share from
12.8 million shekel or 0.06 the year earlier. No analyst estimates
were available for comparison.
Finally, ISIS Pharmaceuticals (
) Tuesday said it has begun the Phase 1 clinical study of ISIS-PKK,
used to treat patients with hereditary angioedemia (
), a rare genetic disease. ISIS-PKK is designed to alter the course
Shares in the drug developer were steady in
on Tuesday and were last at $24.75 Monday after hours.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.